Group 1 - The company plans to invest up to 90 million yuan of its own funds to ensure the normal production and operation of Jilin COFCO Biochemical Packaging Co., Ltd [1] - After the capital increase, Changheng Co., Ltd. will hold no less than 36.9603% of the equity in Jilin COFCO Biochemical Packaging Co., Ltd., while the company will hold no more than 63.0397% [1] - As of December 31, 2024, Jilin COFCO Biochemical Packaging Co., Ltd. had total assets of 124 million yuan, total liabilities of 104 million yuan, and net assets of 20.6659 million yuan [1] Group 2 - For the fiscal year 2024, the company reported an operating income of 109 million yuan and a net profit of -58.9147 million yuan [1] - As of June 30, 2025, the total assets of Jilin COFCO Biochemical Packaging Co., Ltd. were 98.959 million yuan, total liabilities were 94.8839 million yuan, and net assets were 4.0751 million yuan [1] - For the first half of 2025, the company reported an operating income of 41.2235 million yuan and a net profit of -16.5908 million yuan [1]

中粮科技公告，为确保吉林中粮生化包装有限公司正常生产经营活动，拟使用不超过9000万元自有资金 进行增资。增资完成后，昌衡有限公司持有吉林中粮生化包装有限公司不低于36.9603%的股权，公司 持有不超过63.0397%的股权。2024年12月31日，吉林中粮生化包装有限公司资产总额为1.24亿元，负债 总额为1.04亿元，净资产为2066.59万元。2024年度营业收入为1.09亿元，净利润为-5891.47万元。2025 年6月30日，资产总额为9895.9万元，负债总额为9488.39万元，净资产为407.51万元。2025年1—6月营 业收入为4122.35万元，净利润为-1659.08万元。 ...

九届董事会四次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏。 证券代码：000930 证券简称：中粮科技 公告编号：2025-075 中粮生物科技股份有限公司 一、会议出席情况 中粮生物科技股份有限公司（以下简称公司）于 2025 年 9 月 27 日分别以电子邮 件和专人送达的方式向公司全体董事、监事和高级管理人员发出召开九届董事会四次 会议的书面通知。会议于 2025 年 10 月 14 日如期召开。在保障所有董事充分表达意 见的情况下，本次董事会采用现场结合通讯方式进行表决。本次董事会会议材料同时 提交公司监事及高级管理人员审阅。会议应参加表决董事 7 人，实际参加表决的董事 共 7 人，参加表决的董事有：江国金先生、张德国先生、郭斐女士、郑合山先生、张 念春先生、汪平先生、马莺女士，符合《公司法》和《公司章程》的相关规定。 二、议案审议情况 1.以 7 票同意、0 票反对、0 票弃权的表决结果审议通过了《关于向吉林中粮生 化包装有限公司股权增资的议案》 具体内容详见同日刊登在巨潮资讯网、《中国证券报》《证券时报》《证券日报》《上 海证券报》的 ...

Core Insights - D-Allulose, a new low-GI sweetener, has been approved for commercial use in China, with significant industry interest and potential applications in food products [1][2][4] - The global market for D-Allulose is projected to reach $14.77 million in 2024, with a compound annual growth rate (CAGR) exceeding 14% from 2025 to 2034 [3] Industry Overview - The approval of D-Allulose aligns with the "Healthy China Action (2019-2030)" initiative, which aims to limit daily added sugar intake to 25 grams per person by 2030 [1] - D-Allulose is recognized for its sugar-like taste, low caloric content (1.67 kJ/g or 0.4 kcal/g), and potential health benefits, including no impact on blood lipids or uric acid levels [2] Production and Supply Chain - D-Allulose can be produced through two main methods: fermentation using E. coli and enzyme-catalyzed conversion [4][5] - Companies like COFCO and Zhongda Hengyuan are actively developing production capabilities, with COFCO utilizing self-developed enzymes for production [5] - The production process is complex, with a need for advanced technology and significant initial investment, leading to a competitive landscape among producers [4][5] Market Dynamics - Downstream companies, including Wahaha and Mengniu, are showing interest in D-Allulose, but large-scale application is still in the testing phase [6][7] - The current cost of D-Allulose is significantly higher than other sweeteners, with prices ranging from 20,000 to 24,000 yuan per ton, compared to around 10,000 yuan per ton for erythritol [8] Future Prospects - The industry is optimistic about D-Allulose's potential, citing its broader application scenarios compared to erythritol, particularly in products sensitive to crystallization [10] - Key factors for market success include ongoing technological innovation, cost control, and the establishment of a complete industry ecosystem [10]

证券代码：000930 证券简称：中粮科技 公告编号：2025-074 中粮生物科技股份有限公司 关于D-阿洛酮糖产品发布的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗漏。 一、产品简介 2025年9月23日，中粮集团D-阿洛酮糖科技成果交流暨产品发布会在北京举行。中粮生物科技股份有限 公司（以下简称 公司）作为此次活动的承办单位，推出面向食品工业客户，涵盖饮料、乳制品、烘 焙、现制茶饮及咖啡等领域的D-阿洛酮糖产品，为其提供包括配方支持在内的综合解决方案。该产品 应用公司与中粮营养健康研究院联合开发的酶法生产工艺，具备纯正口感且无后苦味特征，其甜度相当 于蔗糖的70%，而热量为蔗糖的10%，匹配低热量糖类摄入需求趋势。该产品还能与蛋白质发生美拉德 反应，可广泛应用于存在美拉德反应着色及风味强化需求的烘焙、饮料等食品领域。 二、对公司的影响 D-阿洛酮糖的推出，凭借其先进的生物技术创新，进一步丰富了公司的产品结构，为公司开拓新兴市 场、培育新的业务增长点创造了有利条件。 三、风险提示 本次推出的新产品的销售情况将取决于市场规模和市场认可度，公司尚无法预测对公司经营 ...

据证券时报报道，9月23日，中粮生物科技、中粮营养健康研究院联合研发生产的国内首个D-阿洛酮糖 产品在北京正式发布上市。中粮集团此次推出的阿洛酮糖产品不仅填补了国内高端功能糖市场的空白， 更标志着我国在生物制造领域打破国际技术垄断。 点评：D-阿洛酮糖作为代糖，广泛应用于饮料、烘焙、乳制品等领域。3月23日，中国食品科学技术学 会食品营养与健康分会发布《D-阿洛酮糖的科学共识》称，D-阿洛酮糖低能量且不升血糖，是一种具 有产业应用潜力的天然甜味物质，可作为食品添加糖的代替品，且其安全性已经得到广泛认可，多国均 已批准在食品中使用。 百龙创园：是国内首家具备工业化生产阿洛酮糖的企业。 保龄宝：是国内最早布局阿洛酮糖项目的企业之一，公司目前有超5000吨在运行产能，2025年3月启动 产能扩建，根据不同产品结构，预计26年达到3万吨产能。 *免责声明：文章内容仅供参考，不构成投资建议 *风险提示：股市有风险，入市需谨慎 根据Global Market Insight数据，2024年全球D-阿洛酮糖市场规模已达1.47亿美元，预计2025-2034年期 间将以14%的年复合增长率快速增长。7月2日，国家卫生健康委、 ...

Group 1 - The core viewpoint of the article is the launch of China's first D-Tagatose product developed by COFCO Biotechnology and COFCO Nutrition and Health Research Institute, marking a significant advancement in the alternative sweetener market [1] - D-Tagatose is a six-carbon ketose sugar that is naturally found in small amounts in various plants such as figs, kiwis, and wheat, with a sweetness level approximately 70% that of sucrose and only about 10% of its calories, positioning it as a new type of sugar substitute following erythritol [1] - Several downstream companies, including Bawang Tea Ji, Qu Tea Mountain, Beijing Daoxiangcun, Mengniu Dairy, and Harbin Qiulin Beverage, have signed intention orders with COFCO Biotechnology for products made with D-Tagatose, indicating strong market interest and potential demand [1] Group 2 - In July of this year, the National Health Commission of China officially approved D-Tagatose as a new food ingredient, which is expected to facilitate its integration into the food and beverage industry [1]

Group 1 - The core event is the announcement of the D-Allulose technology achievement exchange and product launch conference by COFCO Technology, scheduled for September 23, 2025, in Beijing [2] - COFCO Technology will introduce D-Allulose products aimed at food industry clients, covering sectors such as beverages, dairy products, baking, ready-to-drink tea, and coffee [2] - The company will provide comprehensive solutions, including formulation support, to its clients in the food industry [2]

Group 1 - The core event is the D-allohexose technology achievement exchange and product launch held by COFCO Technology on September 23, 2025, in Beijing [1] - The company introduced D-allohexose products aimed at food industry clients, covering sectors such as beverages, dairy products, baking, and ready-to-drink tea and coffee [1] - The product utilizes an enzyme production process developed in collaboration with COFCO Nutrition and Health Research Institute, featuring a pure taste without a bitter aftertaste [1] Group 2 - The sweetness of the D-allohexose product is equivalent to 70% of sucrose, while its caloric content is only 10% of that of sucrose, aligning with the trend for low-calorie sugar alternatives [1] - The product can undergo Maillard reaction with proteins, making it suitable for applications in baking and beverages where color and flavor enhancement are required [1]

D-阿洛酮糖产品的成功上市标志着公司在高端功能糖领域自主研发与产业化取得实质性突破。当前公 司产能规划划分为三个阶段推进：近期已与合作伙伴构建供应链体系，依托现有设备实施生产；中期规 划通过设备技术改造实现产能扩充；长期规划以新建生产线建立完整生产体系。 格隆汇9月23日丨中粮科技(000930.SZ)公布，中粮集团D-阿洛酮糖科技成果交流暨产品发布会在北京举 行。中粮生物科技股份有限公司作为此次活动的承办单位，推出面向食品工业客户，涵盖饮料、乳制 品、烘焙、现制茶饮及咖啡等领域的D-阿洛酮糖产品，为其提供包括配方支持在内的综合解决方案。 该产品应用公司与中粮营养健康研究院联合开发的酶法生产工艺，具备纯正口感且无后苦味特征，其甜 度相当于蔗糖的70%，而热量为蔗糖的10%，匹配低热量糖类摄入需求趋势。该产品还能与蛋白质发生 美拉德反应，可广泛应用于存在美拉德反应着色及风味强化需求的烘焙、饮料等食品领域。 ...